CIP
CVS icon

Chartwell Investment Partners’s CVS Health CVS Stock Holding History

Chartwell Investment Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,625
Closed -$286K – 419
2023
Q4 		$286K Sell
3,625
-16
-0.4% -$1.14K 0.01% 413
2023
Q3 		$254K Sell
3,641
-364
-9% -$25.8K 0.01% 409
2023
Q2 		$277K Buy
4,005
+1,233
+44% +$87.7K 0.01% 405
2023
Q1 		$206K Buy
2,772
+128
+5% +$10.7K 0.01% 408
2022
Q4 		$246K Sell
2,644
-50,966
-95% -$4.92M 0.01% 402
2022
Q3 		$5.11M Buy
53,610
+462
+0.9% +$45.7K 0.22% 170
2022
Q2 		$4.92M Sell
53,148
-5,504
-9% -$537K 0.2% 177
2022
Q1 		$5.94M Sell
58,652
-4,105
-7% -$431K 0.2% 178
2021
Q4 		$6.47M Buy
+62,757
New +$5.8M 0.19% 189
2019
Q2 		– Sell
-136,092
Closed -$7.34M – 415
2019
Q1 		$7.34M Buy
136,092
+5,939
+5% +$367K 0.24% 159
2018
Q4 		$8.53M Buy
130,153
+27,177
+26% +$2.03M 0.3% 113
2018
Q3 		$8.11M Buy
102,976
+25,496
+33% +$1.82M 0.24% 152
2018
Q2 		$4.99M Buy
+77,480
New +$5.11M 0.15% 202
2017
Q3 		– Sell
-60,000
Closed -$4.83M – 417
2017
Q2 		$4.83M Hold
60,000
– – 0.18% 171
2017
Q1 		$4.71M Hold
60,000
– – 0.17% 181
2016
Q4 		$4.74M Sell
60,000
-15,500
-21% -$1.25M 0.16% 192
2016
Q3 		$6.72M Buy
75,500
+6,500
+9% +$614K 0.12% 217
2016
Q2 		$6.61M Buy
69,000
+2,000
+3% +$199K 0.12% 207
2016
Q1 		$6.95M Hold
67,000
– – 0.13% 176
2015
Q4 		$6.55M Buy
67,000
+5,000
+8% +$490K 0.13% 190
2015
Q3 		$5.98M Buy
62,000
+12,000
+24% +$1.26M 0.13% 198
2015
Q2 		$5.24M Buy
50,000
+2,000
+4% +$204K 0.1% 218
2015
Q1 		$4.95M Buy
+48,000
New +$4.86M 0.1% 233

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Chartwell Investment Partners's CVS Position: Q1 2024 in Review

Chartwell Investment Partners sold out of CVS Health (CVS) in Q1 2024, closing a stake of 3,625 shares — an estimated $286K sold.

Chartwell Investment Partners first reported a position in CVS in Q1 2015 and held it in 23 quarters. The position peaked at $8.53M in Q4 2018. 2,176 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

  • Chartwell Investment Partners reported no remaining CVS Health position as of Q1 2024 after selling out during the quarter.
  • Chartwell Investment Partners sold 3,625 CVS Health shares in Q1 2024, an estimated $286K.
  • Chartwell Investment Partners first reported a position in CVS Health in Q1 2015 and held it in 23 quarters.
  • Chartwell Investment Partners's CVS Health position peaked at $8.53M in Q4 2018.
  • 2,176 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Chartwell Investment Partners's 13F filing for Q1 2024, filed 14 May 2024.